NEWS & UPDATES
SAFETY ALERTS FOR MEDICINES AND ALLIED SUBSTANCES.
While medicines and vaccines are studied in well controlled clinical trials and reviewed by regulatory authorities with the aim of ensuring benefits outweigh risks, some adverse effects are observed only once the product is authorized by regulators and used by a larger population in real world conditions. It is therefore essential that medical products continue to be monitored for their effectiveness and safety post release.
MEDICAL PRODUCT ALERT NO. 7/2025:FALSIFIED IBRANCE (PALBOCICLIB) IDENTIFIED IN THE WHO AFRICAN, EASTERN MEDITERRANEAN AND EUROPEAN REGIONS
Public Notice - Falsified Ibrance (Palbociclib)Download
MEDICAL PRODUCT ALERT NO.6 /2025: FALSIFIED SIMULECT (BASILIXIMAB) FOR INJEJECTION IDENTIFIED IN THE WHO AFRICAN AND EUROPEAN REGIONS
Medical Product Alert No_6-2025Download
MEDICAL PRODUCT ALERT NO. 5/2025: SUBSTANDARD (CONTAMINATED) ORAL LIQUID MEDICINES IDENTIFIED IN THE WHO SOUTH-EAST ASIA REGION
Reviewed_WHO Alert No. 5.2025_contaminated syrups_15102025.Download
PARTNERS
